Targeting Mitochondrial DNA with a Platinum-Based Anticancer Agent

Author(s)
Wisnovsky, Simon P.; Wilson, Justin J.; Radford, Robert J.; Pereira, Mark P.; Chan, Maria R.; ... Show more
Thumbnail
DownloadLippard_Targeting mitochondrial.pdf (1.064Mb)
PUBLISHER_POLICY
Terms of use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Metadata
Show full item record
Abstract
An analog of the anticancer drug cisplatin (mtPt) was delivered to mitochondria of human cells using a peptide specifically targeting this organelle. mtPt induces apoptosis without damaging nuclear DNA, indicating that mtDNA damage is sufficient to mediate the activity of a platinum-based chemotherapeutic. This study demonstrates the specific delivery of a platinum drug to mitochondria and investigates the effects of directing this agent outside the nucleus.
Date issued
2013-10
URI
http://hdl.handle.net/1721.1/95474
Department
Massachusetts Institute of Technology. Department of Chemistry
Journal
Chemistry and Biology
Publisher
Elsevier
Citation
Wisnovsky, Simon P., Justin J. Wilson, Robert J. Radford, Mark P. Pereira, Maria R. Chan, Rebecca R. Laposa, Stephen J. Lippard, and Shana O. Kelley. “Targeting Mitochondrial DNA with a Platinum-Based Anticancer Agent.” Chemistry & Biology 20, no. 11 (November 2013): 1323–1328. © 2013 Elsevier Ltd.
Version: Final published version
ISSN
10745521
Collections